User: prashantiyengar Topic: IP
Category: drugs :: india
Last updated: Jun 24 2017 11:46 IST RSS 2.0
 
1 to 20 of 2,783    
Modi urged to remain committed to affordable drugs during meeting with Trump 24.6.2017 TOI: India
Also found in: [+]
Modi urged to remain committed to affordable dedicines during meeting with Trump 23.6.2017 TOI: India
Also found in: [+]
How a leadership flux, and consequent tinkering in strategy has taken a toll on Cipla 13.6.2017 ET: Pharma
Heads of Europe and US operations Frank Pieters and Tim Crew are both gone, as is Subhanu Saxena, the MD who was hired from Novartis in 2012.
Also found in: [+]
Transfer of IP assets by pharma firms to abroad under RBI scrutiny 29.5.2017 ET: Pharma
Several pharma cos including some of the leading ones have over the years steadily transferred most of their IPs outside India and reduced their tax burden in the country.
Also found in: [+]
Roche vs Indian Pharma: The battle for a cheaper cancer drug 14.5.2017 ET: Pharma
The companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first woman pharma-billionaire, Kiran Mazumdar-Shaw.
Also found in: [+]
'India's IPR policy a good first step, needs to address gaps' 13.5.2017 ET: Policy
Both, the companies in the United States and the Trump administration have been expressing concerns over some aspects of the Indian IPR policy.
Also found in: [+]
Doctors fear pharmacists will push for generic drugs that give max profit 1.5.2017 ET: Pharma
Generic drugs sold under a brand name given by the manufacturer are called branded generics. In India, 90% of the pharma market is made up of such branded generic drug
Also found in: [+]
Working to cut patent examination time to 18 months: Nirmala Sitharaman 27.4.2017 ET: Policy
The ministry is continuously working on simplification of rules and reducing the patent examination time, Commerce and Industry Minister Nirmala Sitharaman said.
Also found in: [+]
Prescribing generic medicines already a must under MCI rules 19.4.2017 TOI: India
While PM Modi has said that “legal arrangements“ will be made to make prescription of generic medicines compulsory, the fact is that this is already mandatory . The Medical Council of India's ethics code for docs made generic prescription mandatory in October 2016, though it has never been enforced.
Also found in: [+]
PM's push for generic drugs to shift focus to chemists, says pharma industry body 18.4.2017 ET: Pharma
Patients may end up with drugs that "may not be effective at all" if doctors were made to prescribe only generic medicines,, according to pharma industry body IPA.
Also found in: [+]
IPA punches holes into drug pricing policy implementation 4.4.2017 ET: Pharma
"This is not a good sign. It is indicative of trust deficit in the regulatory mechanism and administrative machinery, be it the NPPA or CDSCO," it added.
Also found in: [+]
Union HRD Minister Prakash Javadekar Releases ‘India Rankings 2017’ 3.4.2017 Govt of india: PIB
The Union Minister of Human Resource Development, Shri Prakash Javadekar , released the India Rankings 2017 for the Educational Institutions and dedicated it to the nation in New Delhi today. Speaking on the occasion he said that this step is a sequel of our Government’s commitment towards bringing
Also found in: [+]
`India–EFTA trade talks may adversely impact access to medicines in developing countries' 23.3.2017 TOI: India
Also found in: [+]
Delhi HC dismisses Cipla's plea against single judge order 9.3.2017 ET: Pharma
The observation by the court came while dismissing Indian pharma company Cipla's bid to make and sell a generic version of Swiss drug major Novartis' patented respiratory disease medicine Indacaterol without a compulsory licence.
Also found in: [+]
Delhi High Court quashes Cipla's appeal, says it can't market generics of Novartis' Onbrez 9.3.2017 ET: Pharma
The court said it can't make a definitive conclusion that Novartis' imports of Onbrez were insufficient to meet the demands COPD patients from the data that was submitted by Cipla and Novartis during the hearings.
Also found in: [+]
Indian drug makers can export patented meds for approval: Delhi High Court 8.3.2017 ET: Pharma
Natco and Alembic, however, were directed to undertake that during the life of the respective patent, they will not export the respective patented invention for purposes other than those specified in section 107A.
Also found in: [+]
Delhi High Court favours Natco, Alembic; allows them to export generics of Bayer's drugs 8.3.2017 ET: Pharma
Bayer had approached court in 2016 to stop Alembic Pharmaceuticals from exporting its generic of the German company's blood thinner brand 'Xarelto' (Rivaroxaban), used to prevent and treat dangerous blood clots.
Also found in: [+]
Pharma lobby cries foul on GIPC’s poor ranking to India 3.3.2017 ET: Pharma
Global Intellectual Property Centre (GIPC) index on intellectual property (IP) standards once again places India at the bottom of 45 countries.
Also found in: [+]
BUZZ-India's Dr. Reddy's Labs hits over 1-year low; firm's drug infringes U.S. patents 16.2.2017 Sify Finance
** Shares of Dr Reddy's Laboratories fall as much as 3.9 pct, their lowest since Jan 22, 2016
Also found in: [+]
Healthcare and patient groups oppose patents on crucial hepatitis C drugs 15.2.2017 TOI: India
Also found in: [+]
1 to 20 of 2,783